These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21868742)

  • 1. Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage.
    Selim M; Yeatts S; Goldstein JN; Gomes J; Greenberg S; Morgenstern LB; Schlaug G; Torbey M; Waldman B; Xi G; Palesch Y;
    Stroke; 2011 Nov; 42(11):3067-74. PubMed ID: 21868742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods.
    Yeatts SD; Palesch YY; Moy CS; Selim M
    Neurocrit Care; 2013 Oct; 19(2):257-66. PubMed ID: 23943316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial.
    Selim M; Foster LD; Moy CS; Xi G; Hill MD; Morgenstern LB; Greenberg SM; James ML; Singh V; Clark WM; Norton C; Palesch YY; Yeatts SD;
    Lancet Neurol; 2019 May; 18(5):428-438. PubMed ID: 30898550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage.
    Farr AC; Xiong MP
    Mol Pharm; 2021 Feb; 18(2):593-609. PubMed ID: 32926630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical effect of deferoxamine mesylate on edema after intracerebral hemorrhage.
    Yu Y; Zhao W; Zhu C; Kong Z; Xu Y; Liu G; Gao X
    PLoS One; 2015; 10(4):e0122371. PubMed ID: 25875777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
    Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
    Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage.
    Mayer SA; Brun NC; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
    Stroke; 2005 Jan; 36(1):74-9. PubMed ID: 15569871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial.
    Lyden PD; Shuaib A; Lees KR; Davalos A; Davis SM; Diener HC; Grotta JC; Ashwood TJ; Hardemark HG; Svensson HH; Rodichok L; Wasiewski WW; Ahlberg G;
    Stroke; 2007 Aug; 38(8):2262-9. PubMed ID: 17569876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermo-sensitive keratin hydrogel against iron-induced brain injury after experimental intracerebral hemorrhage.
    Zhu Q; Gong Y; Guo T; Deng J; Ji J; Wang B; Hao S
    Int J Pharm; 2019 Jul; 566():342-351. PubMed ID: 31158456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perihematomal Edema Expansion Rates and Patient Outcomes in Deep and Lobar Intracerebral Hemorrhage.
    Grunwald Z; Beslow LA; Urday S; Vashkevich A; Ayres A; Greenberg SM; Goldstein JN; Leasure A; Shi FD; Kahle KT; Battey TW; Simard JM; Rosand J; Kimberly WT; Sheth KN
    Neurocrit Care; 2017 Apr; 26(2):205-212. PubMed ID: 27844466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain edema after intracerebral hemorrhage in rats: the role of iron overload and aquaporin 4.
    Qing WG; Dong YQ; Ping TQ; Lai LG; Fang LD; Min HW; Xia L; Heng PY
    J Neurosurg; 2009 Mar; 110(3):462-8. PubMed ID: 19025353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload.
    Piga A; Galanello R; Forni GL; Cappellini MD; Origa R; Zappu A; Donato G; Bordone E; Lavagetto A; Zanaboni L; Sechaud R; Hewson N; Ford JM; Opitz H; Alberti D
    Haematologica; 2006 Jul; 91(7):873-80. PubMed ID: 16818273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative systolic blood pressure reduction and clinical outcomes in hyperacute intracerebral hemorrhage: the SAMURAI-ICH observational study.
    Sakamoto Y; Koga M; Todo K; Okuda S; Okada Y; Kimura K; Shiokawa Y; Kamiyama K; Furui E; Hasegawa Y; Kario K; Okata T; Kobayashi J; Tanaka E; Yamagami H; Nagatsuka K; Minematsu K; Toyoda K;
    J Hypertens; 2015 May; 33(5):1069-73. PubMed ID: 25668358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study.
    Fu Y; Hao J; Zhang N; Ren L; Sun N; Li YJ; Yan Y; Huang D; Yu C; Shi FD
    JAMA Neurol; 2014 Sep; 71(9):1092-101. PubMed ID: 25003359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deferoxamine reduces CSF free iron levels following intracerebral hemorrhage.
    Wan S; Hua Y; Keep RF; Hoff JT; Xi G
    Acta Neurochir Suppl; 2006; 96():199-202. PubMed ID: 16671454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deferoxamine in intracerebral hemorrhage: Systematic review and meta-analysis.
    Sun T; Zhao YY; Xiao QX; Wu M; Luo MY
    Clin Neurol Neurosurg; 2023 Apr; 227():107634. PubMed ID: 36857886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deferoxamine therapy for intracerebral hemorrhage.
    Hua Y; Keep RF; Hoff JT; Xi G
    Acta Neurochir Suppl; 2008; 105():3-6. PubMed ID: 19066072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of desferrioxamine mesylate in intracerebral hematoma: a systemic review and meta-analysis.
    Zhao K; Li J; Zhang Q; Yang M
    Neurol Sci; 2022 Dec; 43(12):6771-6782. PubMed ID: 36006553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Location-specific differences in hematoma volume predict outcomes in patients with spontaneous intracerebral hemorrhage.
    Ironside N; Chen CJ; Dreyer V; Christophe B; Buell TJ; Connolly ES
    Int J Stroke; 2020 Jan; 15(1):90-102. PubMed ID: 30747614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the original, modified, or new intracerebral hemorrhage score to predict mortality and morbidity after intracerebral hemorrhage.
    Cheung RT; Zou LY
    Stroke; 2003 Jul; 34(7):1717-22. PubMed ID: 12805488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.